Wang J, Ahimaz P, Hashemifar S, Khlevner J, Picoraro J, Middlesworth W
Eur J Hum Genet. 2020; 29(1):122-130.
PMID: 32641753
PMC: 7852873.
DOI: 10.1038/s41431-020-0680-2.
Quenez O, Cassinari K, Coutant S, Lecoquierre F, Le Guennec K, Rousseau S
Eur J Hum Genet. 2020; 29(1):99-109.
PMID: 32591635
PMC: 7852510.
DOI: 10.1038/s41431-020-0672-2.
Kim S, Chang L
Neurogastroenterol Motil. 2012; 24(10):895-913.
PMID: 22863120
PMC: 3812246.
DOI: 10.1111/j.1365-2982.2012.01993.x.
Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R
Pharmacoeconomics. 2006; 24(1):21-37.
PMID: 16445300
DOI: 10.2165/00019053-200624010-00002.
Luscombe F
Qual Life Res. 2000; 9(2):161-76.
PMID: 10983480
DOI: 10.1023/a:1008970312068.
Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants.
Paterson W, Thompson W, Vanner S, Faloon T, Rosser W, Birtwhistle R
CMAJ. 1999; 161(2):154-60.
PMID: 10439825
PMC: 1230466.
Coeliac disease in primary care: case finding study.
Hin H, Bird G, Fisher P, Mahy N, Jewell D
BMJ. 1999; 318(7177):164-7.
PMID: 9888912
PMC: 27697.
DOI: 10.1136/bmj.318.7177.164.
The irritable bowel syndrome.
Francis C, Whorwell P
Postgrad Med J. 1997; 73(855):1-7.
PMID: 9039402
PMC: 2431185.
DOI: 10.1136/pgmj.73.855.1.
Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome.
Nolen 3rd H, Friend D
Pharm Res. 1994; 11(12):1707-11.
PMID: 7899232
DOI: 10.1023/a:1018950930134.
Alternatives to medicine.
Thompson W
CMAJ. 1990; 142(2):105-6.
PMID: 2295027
PMC: 1451708.
Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial.
Dobrilla G, Imbimbo B, Piazzi L, Bensi G
Gut. 1990; 31(3):355-8.
PMID: 2182401
PMC: 1378284.
DOI: 10.1136/gut.31.3.355.
The extracolonic manifestations of the irritable bowel syndrome.
Tilbe K, Sullivan S
CMAJ. 1990; 142(6):539-40.
PMID: 2178758
PMC: 1451866.